Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.

Biotechnology

Education

Dewpoint Therapeutics

Dewpoint Therapeutics' headquarters in Boston, MA, United States

The Dresden office focuses on scientific research and product development, supported by management and financial oversight.

Dresden

Ameet Nathwani

Isaac Klein

Heather Hamel

Clotilde Lagier-Tourenne

Salman Banani

Lucas Pelkmans

Amy Gladfelter

Paul Robustelli

Nicolas Fawzi

Regina Barzilay

Dylan Taatjes

Ibrahim Cissé

Timothy Mitchison

Amir Nashat

Mark Murcko

James Shorter

Bradley Hyman

Alex Holehouse

Rudolf Jaenisch

Robert Langer

Florian Stengel

Richard Kriwacki

Srinivas Akkaraju

Anthony Hyman

Giuseppe Ciaramella

Rohit Pappu

Arup Chakraborty

Richard Young

Olivier Brandicourt

Tarun Kapoor

Geraldine Seydoux

Jürgen Eckhardt

Phillip Sharp

Simon Alberti

Douglas E. Williams

The Advisory Team at Dewpoint Therapeutics provides expert guidance and strategic insights to support the company's mission in applying biomolecular condensates to drug discovery. Comprising seasoned professionals and scientific advisors, the team advises on research direction, potential therapeutic targets, and innovative approaches to address conditions regulated by or arising from condensate dysfunction, including cancer, neurodegeneration, and metabolic diseases.

Advisory Team

The Board of Directors at Dewpoint Therapeutics provides strategic guidance and oversight for the company, ensuring that it adheres to its mission of applying biomolecular condensates to drug discovery. Comprised of experienced professionals, including founders, the Board sets long-term goals, monitors performance, and supports executive leadership in making critical business decisions to advance research and development in conditions such as cancer, neurodegeneration, and metabolic disease.

Board of Directors

This department conducts research and analysis to advance knowledge and support strategic initiatives.

Research Division

The Science and Research team at Dewpoint Therapeutics leverages the groundbreaking field of biomolecular condensates to innovate drug discovery processes. Comprising experts in biology, chemistry, microscopy, and data science, the team conducts cutting-edge research to uncover new therapeutic targets and develop treatments for a wide array of conditions, including cancer, neurodegeneration, and metabolic diseases. This cross-functional group collaborates to map condensate biology, identify potential drug targets, and accelerate the translation of scientific discoveries into clinical solutions.

Science and Research

This department focuses on scientific research and product development to drive innovation and advancements in related fields.

Research and Development

The Accounting and Finance team at Dewpoint Therapeutics manages the company's financial health by overseeing budgeting, financial planning and analysis, and regulatory compliance. They ensure accurate financial reporting, manage internal controls, and provide strategic financial insights to support decision-making in the pioneering field of biomolecular condensates and drug discovery.

Accounting and Finance

Dewpoint Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Board of Directors

Research Division

Science and Research

Research and Development

Accounting and Finance

Offices

Dewpoint Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Board of Directors

Research Division

Science and Research

Research and Development

Accounting and Finance

Offices

Related companies